10.53
+1.67(+18.85%)
Currency In USD
Address
822 A1A North
Ponte Vedra, FL 32082
United States of America
Phone
904 300 0701
Website
Sector
Healthcare
Industry
Biotechnology
Employees
4
First IPO Date
January 20, 2023
| Name | Title | Pay | Year Born |
| Mr. Quang X. Pham | Chairman & Chief Executive Officer | 1.13M | 1965 |
| Mr. Jeffrey Cole | Chief Operating Officer | 615,361 | 1968 |
| Mr. Matthew K. Szot CPA, CPA | Co-Founder & Chief Financial Officer | 712,776 | 1974 |
| Dr. James J. Ferguson FACC, M.D. | Chief Medical Officer | 0 | 1954 |
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.